Mode
Text Size
Log in / Sign up
N/A Completed N=78

PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Reconstruction System

Acetabulum Fracture · Pelvic Ring Fracture
Source: ClinicalTrials.gov NCT05215626 ↗
Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Performance: Fracture Healing — 84; 0 Cases

Summary

The study is a monocentric, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the Reconstruction System (implants and instrumentation) when used for temporary internal fixation and stabilization of fractures during the normal healing process. The primary objective is the assessment of performance by analyzing fracture healing. The secondary objectives are the assessment of safety by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified. Subjects' outcomes will also be assessed.

Outcome Measures

OutcomeResultp-value
PRIMARY
Performance: Fracture Healing
84; 0
SECONDARY
Product Safety
68; 16
SECONDARY
Harris Hip Score
59; 17; 7; 1

Eligibility Criteria

Inclusion Criteria

Patients having received the Zimmer Reconstruction System for temporary internal fixation and stabilization of fractures during the normal healing process

Exclusion Criteria

  • Off-label use
  • Patients under the age of 18
  • Severely comminuted fractures in which bone fragments are too small or numerous to adequately fix or maintain a reduced position
  • Infection
  • Metal sensitivity or intolerance
  • Severe osteopenia and/or osteoporosis, or in the presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor-like condition of the bone which may compromise fixation
  • Sternal or spinal fractures
  • Anatomical location in which the device would interfere with nerves, blood vessels, or other vital structures
  • Patients with inadequate soft tissue coverage at the implant site
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05215626). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search